- Gibtulio Met 12.5 mg/1000 mg Tablet effectively lowers blood sugar levels in adults with Type 2 diabetes.
- This formulation helps improve glycemic control when diet and exercise are insufficient.
- Gibtulio Met 12.5 mg/1000 mg Tablet reduces the risk of cardiovascular events associated with diabetes.
- It combines the benefits of Empagliflozin and Metformin for enhanced blood glucose management.
- Patients using Gibtulio Met 12.5 mg/1000 mg Tablet may experience improved insulin sensitivity.
- This medication aids in the excretion of excess glucose through urine.
- Gibtulio Met 12.5 mg/1000 mg Tablet can help prevent complications related to uncontrolled diabetes.
- Regular use of this therapy supports overall metabolic health in diabetic patients.
Gibtulio Met 12.5 mg/1000 mg Tablet - Strip of 10
Compositions : Empagliflozin 12.5mg + Metformin 1000mg
MRP :
MRP :
In stock
Delivery within 2 to 7 Working Days
Manufacture/Marketer: Lupin Limited
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Description
Gibtulio Met 12.5 mg/1000 mg Tablet is a pharmaceutical formulation specifically designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients: Empagliflozin and Metformin, which work synergistically to control blood sugar levels effectively. The key composition of Gibtulio Met 12.5 mg/1000 mg Tablet includes 12.5 mg of Empagliflozin and 1000 mg of Metformin, making it a potent option for patients struggling with diabetes management. The primary purpose of Gibtulio Met 12.5 mg/1000 mg Tablet is to lower blood glucose levels in adults with Type 2 diabetes, particularly when diet and exercise alone do not suffice. As part of the therapeutic category of antidiabetic medications, this combination therapy not only helps in controlling blood sugar but also offers cardiovascular benefits, reducing the risk of heart-related complications associated with diabetes. The unique formulation of Gibtulio Met 12.5 mg/1000 mg Tablet allows for improved glycemic control, making it an essential part of diabetes management plans for many patients. By utilizing the mechanisms of both Empagliflozin and Metformin, Gibtulio Met 12.5 mg/1000 mg Tablet provides a comprehensive approach to managing diabetes, addressing both insulin sensitivity and glucose excretion. This dual-action makes it a preferred choice among healthcare providers for patients who require more than one medication to achieve optimal blood sugar levels. Overall, Gibtulio Met 12.5 mg/1000 mg Tablet stands out as a reliable option for those seeking effective diabetes management.
Product Details
Gibtulio Met 12.5 mg/1000 mg Tablet operates through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components work together to effectively manage blood glucose levels in individuals with Type 2 diabetes.
- Empagliflozin promotes the excretion of glucose through urine, thereby lowering blood sugar levels.
- Metformin decreases glucose production in the liver and enhances insulin sensitivity.
- Together, they provide a comprehensive approach to glycemic control.
- This combination helps mitigate the risk of diabetes-related complications.
- Gibtulio Met 12.5 mg/1000 mg Tablet also aids in weight management, which is beneficial for diabetic patients.
- The formulation supports cardiovascular health by reducing the likelihood of heart disease.
- By improving metabolic activity, this therapy enhances overall well-being in diabetic individuals.
- Gibtulio Met 12.5 mg/1000 mg Tablet should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one tablet taken orally once daily.
- This medication is best taken with food to minimize gastrointestinal discomfort.
- Patients should adhere to a consistent schedule for taking Gibtulio Met 12.5 mg/1000 mg Tablet to maintain stable blood sugar levels.
- The duration of treatment will be determined by the healthcare provider based on individual response and blood glucose monitoring.
- Regular follow-ups are essential to assess the effectiveness and adjust dosage if necessary.
- Patients should not exceed the prescribed dosage without consulting their doctor.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Gibtulio Met 12.5 mg/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Monitor blood sugar levels consistently to track the medication's effectiveness.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on treatment.
- Stay hydrated by drinking plenty of water, especially if experiencing increased urination.
Safety Advice
Side Effects
- Common side effects of Gibtulio Met 12.5 mg/1000 mg Tablet include nausea and vomiting.
- Some patients may experience urinary tract infections or genital fungal infections.
- Flatulence and dyslipidemia are also reported side effects associated with this medication.
- Polyuria (increased urination) may occur due to the action of Empagliflozin.
- Serious side effects can include dehydration or severe allergic reactions; seek medical attention if these occur.
- Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
- Gibtulio Met 12.5 mg/1000 mg Tablet is contraindicated in patients with severe kidney impairment.
- Individuals with a history of hypersensitivity to any component should avoid this medication.
- Caution is advised for those with liver disease or heart failure; consult a doctor before use.
- Alcohol consumption may increase the risk of hypoglycemia; moderation is recommended.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using this medication.
- Regular monitoring of kidney function is essential during treatment with Gibtulio Met 12.5 mg/1000 mg Tablet.
- Patients should inform their doctor about all medications they are taking to avoid potential interactions.
FAQs
Gibtulio Met 12.5 mg/1000 mg Tablet is primarily used for managing Type 2 diabetes mellitus by lowering blood sugar levels.
2. How should I take Gibtulio Met 12.5 mg/1000 mg Tablet?
This medication should be taken as prescribed by your healthcare provider, typically once daily with food.
3. What are the common side effects of this medication?
Common side effects include nausea, vomiting, urinary tract infections, and increased urination.
4. Can I drink alcohol while taking Gibtulio Met 12.5 mg/1000 mg Tablet?
Alcohol should be consumed in moderation as it may increase the risk of low blood sugar.
5. Who should avoid using this medication?
Patients with severe kidney impairment or hypersensitivity to its components should not use Gibtulio Met 12.5 mg/1000 mg Tablet.
6. How does this medication work?
Gibtulio Met 12.5 mg/1000 mg Tablet combines Empagliflozin and Metformin to lower blood glucose levels through different mechanisms.
7. What precautions should I take while using this medication?
Regular monitoring of kidney function and blood sugar levels is essential while using this medication.
Instructions
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C, away from excess moisture and sunlight
- Keep out of reach of children
- Do not use expired tablets and dispose of unused medicine as instructed by your pharmacist
More Information
| SKU | 401276 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Gibtulio Met 12.5 mg/1000 mg Tablet is a pharmaceutical formulation specifically designed for the management of Type 2 diabetes mellitus. This medication combines two active ingredients: Empagliflozin and Metformin, which work synergistically to control blood sugar levels effectively. The key composition of Gibtulio Met 12.5 mg/1000 mg Tablet includes 12.5 mg of Empagliflozin and 1000 mg of Metformin, making it a potent option for patients struggling with diabetes management. The primary purpose of Gibtulio Met 12.5 mg/1000 mg Tablet is to lower blood glucose levels in adults with Type 2 diabetes, particularly when diet and exercise alone do not suffice. As part of the therapeutic category of antidiabetic medications, this combination therapy not only helps in controlling blood sugar but also offers cardiovascular benefits, reducing the risk of heart-related complications associated with diabetes. The unique formulation of Gibtulio Met 12.5 mg/1000 mg Tablet allows for improved glycemic control, making it an essential part of diabetes management plans for many patients. By utilizing the mechanisms of both Empagliflozin and Metformin, Gibtulio Met 12.5 mg/1000 mg Tablet provides a comprehensive approach to managing diabetes, addressing both insulin sensitivity and glucose excretion. This dual-action makes it a preferred choice among healthcare providers for patients who require more than one medication to achieve optimal blood sugar levels. Overall, Gibtulio Met 12.5 mg/1000 mg Tablet stands out as a reliable option for those seeking effective diabetes management.
- Gibtulio Met 12.5 mg/1000 mg Tablet effectively lowers blood sugar levels in adults with Type 2 diabetes.
- This formulation helps improve glycemic control when diet and exercise are insufficient.
- Gibtulio Met 12.5 mg/1000 mg Tablet reduces the risk of cardiovascular events associated with diabetes.
- It combines the benefits of Empagliflozin and Metformin for enhanced blood glucose management.
- Patients using Gibtulio Met 12.5 mg/1000 mg Tablet may experience improved insulin sensitivity.
- This medication aids in the excretion of excess glucose through urine.
- Gibtulio Met 12.5 mg/1000 mg Tablet can help prevent complications related to uncontrolled diabetes.
- Regular use of this therapy supports overall metabolic health in diabetic patients.
Gibtulio Met 12.5 mg/1000 mg Tablet operates through a dual mechanism involving its active ingredients, Empagliflozin and Metformin. These components work together to effectively manage blood glucose levels in individuals with Type 2 diabetes.
- Empagliflozin promotes the excretion of glucose through urine, thereby lowering blood sugar levels.
- Metformin decreases glucose production in the liver and enhances insulin sensitivity.
- Together, they provide a comprehensive approach to glycemic control.
- This combination helps mitigate the risk of diabetes-related complications.
- Gibtulio Met 12.5 mg/1000 mg Tablet also aids in weight management, which is beneficial for diabetic patients.
- The formulation supports cardiovascular health by reducing the likelihood of heart disease.
- By improving metabolic activity, this therapy enhances overall well-being in diabetic individuals.
- Gibtulio Met 12.5 mg/1000 mg Tablet should be taken as prescribed by a healthcare professional.
- The recommended dosage typically involves one tablet taken orally once daily.
- This medication is best taken with food to minimize gastrointestinal discomfort.
- Patients should adhere to a consistent schedule for taking Gibtulio Met 12.5 mg/1000 mg Tablet to maintain stable blood sugar levels.
- The duration of treatment will be determined by the healthcare provider based on individual response and blood glucose monitoring.
- Regular follow-ups are essential to assess the effectiveness and adjust dosage if necessary.
- Patients should not exceed the prescribed dosage without consulting their doctor.
- Maintain a balanced diet rich in whole grains, fruits, and vegetables while using Gibtulio Met 12.5 mg/1000 mg Tablet.
- Engage in regular physical activity to enhance the effectiveness of this medication.
- Monitor blood sugar levels consistently to track the medication's effectiveness.
- Avoid skipping meals to prevent fluctuations in blood sugar levels while on treatment.
- Stay hydrated by drinking plenty of water, especially if experiencing increased urination.
Side Effects
- Common side effects of Gibtulio Met 12.5 mg/1000 mg Tablet include nausea and vomiting.
- Some patients may experience urinary tract infections or genital fungal infections.
- Flatulence and dyslipidemia are also reported side effects associated with this medication.
- Polyuria (increased urination) may occur due to the action of Empagliflozin.
- Serious side effects can include dehydration or severe allergic reactions; seek medical attention if these occur.
- Consult a healthcare provider if side effects persist or worsen over time.
Precautions and Warnings
- Gibtulio Met 12.5 mg/1000 mg Tablet is contraindicated in patients with severe kidney impairment.
- Individuals with a history of hypersensitivity to any component should avoid this medication.
- Caution is advised for those with liver disease or heart failure; consult a doctor before use.
- Alcohol consumption may increase the risk of hypoglycemia; moderation is recommended.
- Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before using this medication.
- Regular monitoring of kidney function is essential during treatment with Gibtulio Met 12.5 mg/1000 mg Tablet.
- Patients should inform their doctor about all medications they are taking to avoid potential interactions.
Gibtulio Met 12.5 mg/1000 mg Tablet is primarily used for managing Type 2 diabetes mellitus by lowering blood sugar levels.
2. How should I take Gibtulio Met 12.5 mg/1000 mg Tablet?
This medication should be taken as prescribed by your healthcare provider, typically once daily with food.
3. What are the common side effects of this medication?
Common side effects include nausea, vomiting, urinary tract infections, and increased urination.
4. Can I drink alcohol while taking Gibtulio Met 12.5 mg/1000 mg Tablet?
Alcohol should be consumed in moderation as it may increase the risk of low blood sugar.
5. Who should avoid using this medication?
Patients with severe kidney impairment or hypersensitivity to its components should not use Gibtulio Met 12.5 mg/1000 mg Tablet.
6. How does this medication work?
Gibtulio Met 12.5 mg/1000 mg Tablet combines Empagliflozin and Metformin to lower blood glucose levels through different mechanisms.
7. What precautions should I take while using this medication?
Regular monitoring of kidney function and blood sugar levels is essential while using this medication.
Directions for Use
Storage and Disposal
- Store in a cool, dry place below 30°C, away from excess moisture and sunlight
- Keep out of reach of children
- Do not use expired tablets and dispose of unused medicine as instructed by your pharmacist
| SKU | 401276 |
|---|---|
| Country of Manufacture | India |
| Manufacturer Address | Lupin Limited |
| Return/Buy Back policy | Non-returnable |
| Prescription Required | Yes |
| Storage |
|
| Seller | Kogland Commerce Pvt Ltd (TN) |
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
Write Your Own Review
Only registered users can write reviews. Please Sign in or create an account